Skip to main content
Have a personal or library account? Click to login
Exploration of Risk Factors for Type 2 Diabetes among Arabs in Israel Cover

Exploration of Risk Factors for Type 2 Diabetes among Arabs in Israel

Open Access
|May 2019

References

  1. Dijkstra A, Janssen F, De Bakker M, et al. Using spatial analysis to predict health care use at the local level: a case study of type 2 diabetes medication use and its association with demographic change and socioeconomic status. PloS One. 2013; 8(8): e72730. DOI: 10.1371/journal.pone.0072730
  2. Meo SA, Usmani AM and Qalbani E. Prevalence of type 2 diabetes in the Arab world: impact of GDP and energy consumption. Eur Rev Med Pharmacol Sci. 2017; 21: 130312.
  3. International Diabetes Federation. Diabetes Atlas, 5th ed.; 2011. http://diabetesatlas.org/resources/previous-editions.html.
  4. Seuring T, Archangelidi O and Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics. 2015; 33(8): 81131. DOI: 10.1007/s40273-015-0268-9
  5. Coogan PF, White LF, Jerrett M, et al. Air pollution and incidence of hypertension and diabetes mellitus in black women living in Los Angeles clinical perspective. Circulation. 2012; 125(6): 76772. DOI: 10.1161/CIRCULATIONAHA.111.052753
  6. Lee DH, Lee IK, Song K, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999–2002. Diabetes Care. 2006; 29(7): 163844. DOI: 10.2337/dc06-0543
  7. Eze IC, Foraster M, Schaffner E, et al. Long-term exposure to transportation noise and air pollution in relation to incident diabetes in the SAPALDIA study. International Journal of Epidemiology. 2017; 46(4): 111525. DOI: 10.1093/ije/dyx020
  8. Dzhambov AM and Dimitrova DD. Exposures to road traffic, noise, and air pollution as risk factors for type 2 diabetes: A feasibility study in Bulgaria. Noise & Health. 2016; 18(82): 133. DOI: 10.4103/1463-1741.181996
  9. Prasad RB and Groop L. Genetics of type 2 diabetes—Pitfalls and possibilities. Genes. 2015; 6(1): 87123. DOI: 10.3390/genes6010087
  10. Kahn SE, Cooper ME and Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. The Lancet. 2014; 383(9922): 106883. DOI: 10.1016/S0140-6736(13)62154-6
  11. Chatterjee S, Khunti K and Davies MJ. Type 2 diabetes. The Lancet. 2017; 389(10085): 223951. DOI: 10.1016/S0140-6736(17)30058-2
  12. Schulz M, Romppel M and Grande G. Built environment and health: a systematic review of studies in Germany. J Public Health. 2016; 40(1): 815. DOI: 10.1093/pubmed/fdw141
  13. Feng J, Glass TA, Curriero FC, Stewart WF and Schwartz BS. The built environment and obesity: a systematic review of the epidemiologic evidence. Health Place. 2010; 16(2): 17590. DOI: 10.1016/j.healthplace.2009.09.008
  14. Akter S, Goto A and Mizoue T. Smoking and the risk of type 2 diabetes in Japan: A systematic review and meta-analysis. J Epidemiol. 2017; 27(12): 55361. DOI: 10.1016/j.je.2016.12.017
  15. Badran M and Laher I. Type II diabetes mellitus in Arabic-speaking countries. International Journal of Endocrinology; 2012.
  16. Central Bureau of Statistics – Israel. Page title that was reviewed; 2016. http://www.cbs.gov.il/reader/cw_usr_view_SHTML?ID=802 [Access date].
  17. Sharkia R, Mahajnah M, Athamny E, Khatib M, Sheikh-Muhammad A and Zalan A. Changes in marriage patterns among the Arab community in Israel over a 60-year period. J Biosoc Sci. 2016; 48(2): 2837. DOI: 10.1017/S0021932015000103
  18. Treister-Goltzman Y and Peleg R. Literature review of type 2 diabetes mellitus among minority Muslim populations in Israel. World J Diabetes. 2015; 6(1): 1929. DOI: 10.4239/wjd.v6.i1.192
  19. Na’amnih W, Muhsen K, Tarabeia J, Saabneh A and Green MS. Trends in the gap in life expectancy between Arabs and Jews in Israel between 1975 and 2004. Int J Epidemiol. 2010; 39(5): 132432. DOI: 10.1093/ije/dyq073
  20. Kalter-Leibovici O, Chetrit A, Lubin F, et al. Adult-onset diabetes among Arabs and Jews in Israel: a population-based study. Diabet Med. 2012; 29(6): 74854. DOI: 10.1111/j.1464-5491.2011.03516.x
  21. Zucker I, Arditi-Babchuk H, Enav T and Shohat T. Self-reported type 2 diabetes and diabetes-related eye disease in Jews and Arabs in Israel. J Immigr Minor Health. 2016; 18(6): 132833. DOI: 10.1007/s10903-016-0341-2
  22. Jaffe A, Giveon S, Wulffhart L, et al. Adult Arabs have higher risk for diabetes mellitus than Jews in Israel. PloS One. 2017; 12(5): e0176661. DOI: 10.1371/journal.pone.0176661
  23. Sharkia R, Mahajnah M, Sheikh-Muhammad A, Khatib M and Zalan A. Trends in the prevalence of type 2 diabetes mellitus among Arabs in Israel: A community health survey. Glob Adv Res J Med Med Sci. 2018; 7(4): 98104.
  24. King H, Aubert RE and Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21(9): 141431. DOI: 10.2337/diacare.21.9.1414
  25. Channanath AM, Farran B, Behbehani K and Thanaraj TA. State of diabetes, hypertension, and comorbidity in Kuwait: showcasing the trends as seen in native versus expatriate populations. Diabetes Care. 2013; 36(6): e75. DOI: 10.2337/dc12-2451
  26. Ayyagari P, Grossman D and Sloan F. Education and health: evidence on adults with diabetes. Int J Health Care Finance Econ. 2011; 11(1): 3554. DOI: 10.1007/s10754-010-9087-x
  27. Bird Y, Lemstra M, Rogers M and Moraros J. The relationship between socioeconomic status/income and prevalence of diabetes and associated conditions: A cross-sectional population-based study in Saskatchewan, Canada. Int J Equity Health. 2015; 14(1): 93. DOI: 10.1186/s12939-015-0237-0
  28. Goldberg R, Temprosa M, Otvos J, et al. Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. J Clin Endocrinol Metab. 2013; 98(10): 398998. DOI: 10.1210/jc.2013-1452
  29. Chu DT, Nguyet NT, Dinh TC, et al. An update on physical health and economic consequences of overweight and obesity. Diabetes Metab Syndr. 2018; 12(6): 1095100. DOI: 10.1016/j.dsx.2018.05.004
  30. NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. The Lancet. 2016; 387(10027): 151330. DOI: 10.1016/S0140-6736(16)00618-8
  31. Lindström J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003; 26(12): 32306. DOI: 10.2337/diacare.26.12.3230
  32. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD and Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006; 49(2): 28997. DOI: 10.1007/s00125-005-0097-z
  33. Haron Y, Hussein O, Epstein L, Eilat D, Harash B and Linn S. Type 2 diabetes among Circassians in Israel. Isr Med Assoc J. 2006; 8(9): 6226.
DOI: https://doi.org/10.5334/aogh.2350 | Journal eISSN: 2214-9996
Language: English
Published on: May 10, 2019
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2019 Rajech Sharkia, Ahmad Sheikh-Muhammad, Muhammad Mahajnah, Mohammad Khatib, Abdelnaser Zalan, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.